Philip Philip, MD of Karmanos Cancer Institute discusses duration of therapy and whether or not shorter treatments will have the same outcomes for patients with stage III colon cancer. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
What have we learned about duration of therapy in the adjuvant CRC setting?
